The most common grade @-@ adverse events with cetuximab plus pemetrexed were fatigue ( @ -LSB- @ % -RSB- of @ patients ) , acneiform rash ( @ -LSB- @ % -RSB- ) , dyspnoea ( @ -LSB- @ % -RSB- ) , and decreased neutrophil count ( @ -LSB- @ % -RSB- ) , and with pemetrexed alone were dyspnoea ( @ -LSB- @ % -RSB- of @ patients ) , decreased neutrophil count ( @ -LSB- @ % -RSB- ) , and fatigue ( @ -LSB- @ % -RSB- ) .